Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease

Nature

Volumn 386, Issue 6623, 1997, Pages 395-399

  Emerich, Dwaine F ^a,f   Winn, Shelley R ^b   Hantraye, Philippe M ^c   Peschanski, Marc ^d   Chen, Er Yun ^e   Chu, Yaping ^e   McDermott, Patricia ^a   Baetge, E Edward ^a   Kordower, Jeffrey H ^e  

^a CytoTherapeutics Inc   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c CNRS   (France)

^d INSERM   (France)

^e RUSH UNIVERSITY MEDICAL CENTER   (United States)

^f ALKERMES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; CILIARY NEUROTROPHIC FACTOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN CORTEX; CHOLINERGIC SYSTEM; CONTROLLED STUDY; CORPUS STRIATUM; GABAERGIC SYSTEM; HUNTINGTON CHOREA; NERVE CELL DEGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BRAIN; CELL LINE; CILIARY NEUROTROPHIC FACTOR; CORPUS STRIATUM; CRICETINAE; DISEASE MODELS, ANIMAL; FIBROBLASTS; GENE THERAPY; HUMANS; HUNTINGTON DISEASE; MACACA FASCICULARIS; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; PHOTOMICROGRAPHY; QUINOLINIC ACID; RECOMBINANT FUSION PROTEINS;

EID: 0030906578     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/386395a0     Document Type: Article

References (29)

1. Reiner, A. et al. Differential loss of striatal projection neurons in Huntington's disease. Proc. Natl Acad. Sci USA 85, 5733-5737 (1988).
2. Anderson, K. D., Panayotatos, N., Cordoran, T. L., Lindsay, R. M. & Wiegand, S. J. Ciliary neurotroophic factor protects striatal output neurons in an animal model of Huntington's disease. Proc Natl Acad. Sci. USA 93, 7346-7351 (1996).
3. Emerich D. F. et al. Implants of encapsulated human CNTF-producing fibroblasts prevent behavioral deficits and striatal degeneration in a rodent model of Huntington's disease. J. Neurosci. 16, 5168-5181 (1996).
4. Beal, M. F. et al. Replication of the neurochemical characteristics Huntington's disease by quinolinic acid. Nature 321, 168-171 (1986).
5. Beal M. T. Kowall N. W., Swartz, K. J., Ferranti, R. J. & Martin, J. B. Differential sparing of somatostatin-neuropeptide Y and cholinergic neurons following striatal excitotoxin lesions. Synapse 3, 38-47 (1989).
6. Emerich D. F. & Sanberg, P. R. in Neuromethods: Animal Models of Neurological Disease (eds Boulton, A. A. Baker, G. B. & Butterworth, R. F.) Vol. 17, 65-134 (Humana, New Jersey, 1992).
7. Ferrante, R. J., Beal, M. F., Kowall, N. W., Richardson, E. P. & Martin, J. B. Sparing of acetylcholinesterase-containing striatal neurons in Huntington's disease. Brain Res. 415, 178-182 (1987).
8. Roberts, R. C. & DiFiglia, M. Short-and long-term survival of large nurons in the excitotoxic lesioned rat caudate nucleus: a light and electron microscopic study. Synpse 3, 363-371 (1989).
9. Albin R. L. & Greenamyre, J. T. Alternative excitotoxic hypothesis. Neurology 42, 733-738 (1992).
10. Beal, M. F. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann. Neurol. 31, 119-130 (1992).
11. Parker, W. D., Boyson, S. J., Luder, A. S. & Parks, J. K. Evidence for a defect on NADH:ubiquinone oxidoreductase (complex I) in Huntington's disease. Neurology 40, 1231-1234 (1990).
12. Wallace, D. C. W Mitochondrial genetics: A paradigm for aging and degenerative diseases? Science 256, 628-632 (1992).
13. Apfel S. C., Arezzo, J. C., Moran, M. & Kessler, J.A. Effects of administration of ciliary neurotrophic factor on normal motor and sensory peripheral nerves in vivo. Brain Res. 604, 1-6 (1993).
14. Sagot, Y. et al. Polymer encapsulated cell lines genetically engineered to release ciliary neurotrophic factor can slow down progressive motor neuronopathy in the mouse. Eur. J. Neurosci. 7, 1313-1322 (1995).
15. Sendtner, M. et al. Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant progressive motor neuronpathy. Nature 358, 502-504 (1992).
16. Clatterbuck R. E., Price, D. L. & Koliatsos, V. E. Ciliary neurotrophic factor prevents retrograde neuronal death in the adult central nervous system. Proc. Natl Acad. Sci. USA 90, 2222-2226 (1993).
17. Hagg, T., Quon, D., Higaki, J. & Varon, S. Ciliary neurotrophic factor prevents neuronal degeneration and promotes low affinity NGF receptor expression in the adult rat CNS. Neuron 8, 145-158 (1993).
18. Hagg, T. & Varon, S. Ciliary neurotrophic factor prevents degeneration of adult rat substantia nigra dopaminergic neurons in vivo. Proc. Natl Acad. Sci. USA 90, 6315-6319 (1993).
19. Emerich, D. F., Hammang, J. P., Baetge, E. E. & Winn, S. R. Implantation of polymer-encapsulated human nerve growth factor-secreting fibroblasts attenuates the behavioral and neuropathological consequences of quinolinic acid injections into rodent striatum. Exper. Neurol. 130, 141-150 (1994).
20. Frim, D. M. et al. Effects of biologically delivered NGF. BDNF and bFGF on striatal excitotoxic lesions. Neuroreport 4, 67-370 (1993).
21. Frim, D. M. et al. Striatal degeneration induced by mitochondrial blockade is prevented by biologically delivered NGF. J. Neurosci. Res. 35, 452-458 (1993).
22. Schumacher, J. M., Short, M. P., Hyman, B. T., Breakefiled, X. O. & Isacson, O. Intracerebral implantation of nerve growth factor-producing fibroblasts protects striatum against neurotoxic levels of excitatory amino acids. Neuroscience 45, 561-70 (1991).
23. Tulipan, N., Luo, S.-Q., Allen, G. & Whetsell, W. O. Striatal grafts provide sustained protection from kainic and quinolinic acid-induced damage. Exp. Neurol. 102, 325-332 (1988).
24. Choi, D. W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1, 623-634 (1988).
25. Olney, J. W. Excitatory amino acids and neuropsychiatric disorders. Biol. Psychiatr. 26, 505-525 (1989).
26. Baetge, E. E., Suh, Y. H. & Job, T. H. Complete nucleotide and decuced amino acid sequence of bovine phenytethanolamine N-methyltransferase: partial homology with rat tyrosine hydroxylase. Proc. Natl Acad. Sci. USA 83, 5454-5458 (1986).
27. Winn, S. R. et al. Polymer-encapsulated cells genetically modified to secrete human nerve growth factor promote the survival of axotomized septal cholinergic neurons. Proc. Natl Acad. Sci. USA 91, 23-28 (1994).
28. Emerich, D. F. et al. Transplantation of polymer-encapsulated cells genetically modified to secrete human nerve growth factor prevents the loss of degenerating cholinergic neurons in nonhuman primates. J. Comp. Neurol. 349, 148-164 (1994).
29. Kordower, J. H., Chen, E.-Y., Mufson, E. J., Winn, S. R. & Emerich, D. F. Intrastriatal implants of polymer-encapsulated cells genetically modified to secrete human NGF: trophic effects upon cholinergic and noncholinergic neurons. Neuroscience 72, 63-77 (1996).